Cargando…
The SIRT2/cMYC Pathway Inhibits Peroxidation-Related Apoptosis In Cholangiocarcinoma Through Metabolic Reprogramming
Cholangiocarcinoma (CCA) is a malignant cancer with an unknown etiology and an unfavorable prognosis. Most patients are diagnosed at an advanced stage, thus making it essential to find novel curative targets for CCA. Metabolic reprogramming of the tumor cells includes metabolic abnormalities in gluc...
Autores principales: | Xu, Lei, Wang, Lei, Zhou, Lixing, Dorfman, Robert Gregory, Pan, Yida, Tang, Dehua, Wang, Yuming, Yin, Yuyao, Jiang, Chengfei, Zou, Xiaoping, Wu, Jianlin, Zhang, Mingming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441712/ https://www.ncbi.nlm.nih.gov/pubmed/30933885 http://dx.doi.org/10.1016/j.neo.2019.03.002 |
Ejemplares similares
-
SIRT3 elicited an anti‐Warburg effect through HIF1α/PDK1/PDHA1 to inhibit cholangiocarcinoma tumorigenesis
por: Xu, Lei, et al.
Publicado: (2019) -
Low levels of pyruvate induced by a positive feedback loop protects cholangiocarcinoma cells from apoptosis
por: Zhang, Mingming, et al.
Publicado: (2019) -
Correction to: Low levels of pyruvate induced by a positive feedback loop protects cholangiocarcinoma cells from apoptosis
por: Zhang, Mingming, et al.
Publicado: (2019) -
Temporal Requirements of cMyc Protein for Reprogramming Mouse Fibroblasts
por: Heffernan, Corey, et al.
Publicado: (2012) -
Down-regulation of HDAC3 inhibits growth of cholangiocarcinoma by inducing apoptosis
por: Zhang, Mingming, et al.
Publicado: (2017)